Free Trial

Marshall Wace LLP Buys 82,063 Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare logo with Business Services background

Marshall Wace LLP increased its stake in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 714.8% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 93,543 shares of the business services provider's stock after acquiring an additional 82,063 shares during the period. Marshall Wace LLP owned approximately 0.29% of Cross Country Healthcare worth $1,699,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CCRN. Quadrant Capital Group LLC acquired a new stake in Cross Country Healthcare in the fourth quarter valued at $25,000. Plato Investment Management Ltd bought a new position in Cross Country Healthcare during the 4th quarter worth $46,000. Mint Tower Capital Management B.V. acquired a new stake in Cross Country Healthcare in the fourth quarter worth $182,000. Guggenheim Capital LLC bought a new stake in Cross Country Healthcare in the fourth quarter valued at $201,000. Finally, Virtu Financial LLC acquired a new position in shares of Cross Country Healthcare during the third quarter valued at $153,000. Institutional investors and hedge funds own 96.03% of the company's stock.

Analysts Set New Price Targets

CCRN has been the topic of several research reports. Barrington Research reiterated a "market perform" rating and issued a $18.61 price target on shares of Cross Country Healthcare in a research report on Friday, March 14th. JMP Securities reissued a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Finally, StockNews.com assumed coverage on Cross Country Healthcare in a research report on Tuesday. They set a "hold" rating on the stock. Six analysts have rated the stock with a hold rating, According to MarketBeat, Cross Country Healthcare has an average rating of "Hold" and an average target price of $18.41.

Read Our Latest Stock Report on CCRN

Cross Country Healthcare Stock Performance

Shares of CCRN stock traded up $0.08 during trading on Friday, hitting $13.61. 167,388 shares of the company were exchanged, compared to its average volume of 596,142. Cross Country Healthcare, Inc. has a twelve month low of $9.58 and a twelve month high of $18.50. The firm has a market capitalization of $446.22 million, a price-to-earnings ratio of -272.15, a P/E/G ratio of 3.32 and a beta of 0.25. The business's 50-day simple moving average is $15.01 and its 200 day simple moving average is $15.34.

About Cross Country Healthcare

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Should You Invest $1,000 in Cross Country Healthcare Right Now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines